InspireMD Debt-to-Equity Ratio Growth & History (NSPR)
InspireMD's debt-to-equity ratio was 0.06 for fiscal 2025.
View full InspireMD company overviewInspireMD annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.06 | −0.01 | −8.01% |
| 2024 | 2024-12-31 | 0.06 | 0.01 | +9.46% |
| 2023 | 2023-12-31 | 0.06 | −0.03 | −36.22% |
| 2022 | 2022-12-31 | 0.09 | 0.06 | +159.09% |
| 2021 | 2021-12-31 | 0.04 | −0.05 | −56.39% |
| 2020 | 2020-12-31 | 0.08 | −0.04 | −32.29% |
| 2019 | 2019-12-31 | 0.12 | — | — |
| 2016 | 2016-12-31 | 0.66 | — | — |
| 2012 | 2012-06-30 | 0.93 | — | — |
| 2011 | 2011-12-31 | 0.01 | — | — |
InspireMD quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06 | −0.06 | −49.55% |
| Q1 2026 | 2026-03-31 | 0.05 | −0.01 | −19.03% |
| Q4 2025 | 2025-12-31 | 0.06 | −0.01 | −8.01% |
| Q3 2025 | 2025-09-30 | 0.04 | 0.02 | +123.84% |
| Q2 2025 | 2025-06-30 | 0.12 | 0.11 | +636.82% |
| Q1 2025 | 2025-03-31 | 0.06 | 0.03 | +121.97% |
| Q4 2024 | 2024-12-31 | 0.06 | 0.01 | +9.46% |
| Q3 2024 | 2024-09-30 | 0.02 | −0.02 | −54.24% |
| Q2 2024 | 2024-06-30 | 0.02 | −0.00 | −18.88% |
| Q1 2024 | 2024-03-31 | 0.03 | −0.05 | −67.65% |
| Q4 2023 | 2023-12-31 | 0.06 | −0.03 | −36.22% |
| Q3 2023 | 2023-09-30 | 0.04 | −0.04 | −53.00% |
| Q2 2023 | 2023-06-30 | 0.02 | −0.03 | −60.49% |
| Q1 2023 | 2023-03-31 | 0.08 | 0.06 | +252.75% |
| Q4 2022 | 2022-12-31 | 0.09 | 0.06 | +159.09% |
| Q3 2022 | 2022-09-30 | 0.08 | 0.05 | +242.00% |
| Q2 2022 | 2022-06-30 | 0.05 | 0.03 | +136.87% |
| Q1 2022 | 2022-03-31 | 0.02 | 0.00 | +12.22% |
| Q4 2021 | 2021-12-31 | 0.04 | −0.05 | −56.39% |
| Q3 2021 | 2021-09-30 | 0.02 | −0.06 | −72.42% |
| Q2 2021 | 2021-06-30 | 0.02 | −0.01 | −38.54% |
| Q1 2021 | 2021-03-31 | 0.02 | −0.14 | −87.00% |
| Q4 2020 | 2020-12-31 | 0.08 | −0.04 | −32.29% |
| Q3 2020 | 2020-09-30 | 0.08 | −0.05 | −38.92% |
| Q2 2020 | 2020-06-30 | 0.04 | −0.16 | −81.66% |
| Q1 2020 | 2020-03-31 | 0.16 | −0.05 | −22.46% |
| Q4 2019 | 2019-12-31 | 0.12 | — | — |
| Q3 2019 | 2019-09-30 | 0.13 | — | — |
| Q2 2019 | 2019-06-30 | 0.20 | — | — |
| Q1 2019 | 2019-03-31 | 0.20 | — | — |
| Q4 2016 | 2016-12-31 | 0.66 | — | — |
| Q3 2016 | 2016-09-30 | 0.59 | — | — |
| Q2 2015 | 2015-06-30 | 3.02 | — | — |
| Q4 2012 | 2012-06-30 | 0.93 | 0.89 | +2389.10% |
| Q4 2011 | 2011-12-31 | 0.01 | — | — |
| Q3 2011 | 2011-09-30 | 0.02 | — | — |
| Q2 2011 | 2011-06-30 | 0.04 | — | — |
InspireMD debt-to-equity ratio trends
Over the last five fiscal years, InspireMD's debt-to-equity ratio decreased from 0.08 to 0.06, a change of −0.02. The latest reported quarter, Q2 2026, shows 0.06.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InspireMD source filings ↗